Travere Therapeutics announces leadership changes in R&D

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Silence Therapeutics shareholders approve all resolutions at annual meeting Hisse Senetleri 0 1
A Travere therapeutics director Timothy Coughlin sells $500,747 in stock Hisse Senetleri 0 1
A Form 144 Travere Therapeutics For: 13 April Hisse Senetleri 0 22
A Travere therapeutics chief legal officer sells $300k in TVTX stock Hisse Senetleri 0 15
A Travere therapeutics CEO Dube sells $1.8m in TVTX stock Hisse Senetleri 0 20
A Form 144 Travere Therapeutics For: 27 January Hisse Senetleri 0 25
A Travere Therapeutics stock faces FDA uncertainty as FSGS decision looms Hisse Senetleri 0 53
A Heerma, Travere therapeutics CCO, sells $199k in TVTX stock Hisse Senetleri 0 32

Benzer konular

Üst